Asthma - Versorgungsleitlinien.de

NVL Asthma, 2. Auflage
Langfassung
Juli 2011, Version 1.3
260. Ducharme FM. Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent
asthma treatment: systematic review of current evidence. BMJ 2003;326(7390):621.
261. Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M, Edwards L, Rickard KA. Lowdose
inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent
asthma. J Allergy Clin Immunol 2000;105(6 Pt 1):1123-9.
262. Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei LX, Seidenberg BC,
Reiss TF. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A
randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med
1999;130(6):487-95.
263. Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss
TF, Nguyen HH, Bratton DL. Montelukast, a leukotriene receptor antagonist, for the
treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001;108(3):E48.
264. Gibson PG, Powell H, Ducharme FM. Differential effects of maintenance long-acting betaagonist
and inhaled corticosteroid on asthma control and asthma exacerbations. J Allergy
Clin Immunol 2007;119(2):344-50.
265. Masoli M, Weatherall M, Holt S, Beasley R. Moderate dose inhaled corticosteroids plus
salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax
2005;60(9):730-4.
266. Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.
Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose
of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst
Rev 2005;(4):CD005533.
267. Masoli M, Weatherall M, Holt S, Beasley R. Systematic review of the dose-response relation of
inhaled fluticasone propionate. Arch Dis Child 2004;89(10):902-7.
268. Shapiro G, Mendelson L, Kraemer MJ, Cruz-Rivera M, Walton-Bowen K, Smith JA. Efficacy and
safety of budesonide inhalation suspension (Pulmicort Respules) in young children with
inhaled steroid-dependent, persistent asthma. J Allergy Clin Immunol 1998;102(5):789-96.
269. Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of asthma.
Evidence table 4.11a: add-on drugs for inhaled steroids: cromones. Edinburgh: 2008 [cited:
2008 Dez 04]. Available from:
http://www.sign.ac.uk/guidelines/published/support/guideline101/index.html
270. Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of asthma.
Evidence table 4.11c: add-on drugs for inhaled steroids: anticholinergics. Edinburgh: 2008
[cited: 2008 Dez 04]. Available from:
http://www.sign.ac.uk/guidelines/published/support/guideline101/index.html
271. Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of asthma.
Evidence table 4.11d: add-on drugs for inhaled steroids: theophylline, beclomethasone,
diproponate, budesonide. Edinburgh: 2008 [cited: 2008 Dez 04]. Available from:
http://www.sign.ac.uk/guidelines/published/support/guideline101/index.html
272. Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of asthma.
Evidence table 4.11b: add-on drugs for inhaled steroids: Long acting or oral B2 agonists.
Edinburgh: 2008 [cited: 2008 Dez 04]. Available from:
http://www.sign.ac.uk/guidelines/published/support/guideline101/index.html
Gilt nur für
Erwachsene
Gilt nur für
Kinder/Jugendliche
Allgemeine
Empfehlungen
© 2009 219